相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H. Abdul-Aziz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
Joel M. Dulhunty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Comparison of different equations to assess glomerular filtration in critically ill patients
Mieke Carlier et al.
INTENSIVE CARE MEDICINE (2015)
Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controll edtrial of continuous infusion versus intermittent bolus administration
Janattul-Ain Jamal et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration
Janattul-Ain Jamal et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
Mohd H. Abdul-Aziz et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study)
Mahiran Mustafa et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Standard Versus Prolonged Doripenem Infusion for Treatment of Gram-Negative Infections
Lama Hsaiky et al.
ANNALS OF PHARMACOTHERAPY (2013)
Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
Karri A. Bauer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
Gloria Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Joel M. Dulhunty et al.
CLINICAL INFECTIOUS DISEASES (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study
Pattarachai Kiratisin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Continuous beta-lactam infusion in critically ill patients: the clinical evidence
Mohd H. Abdul-Aziz et al.
ANNALS OF INTENSIVE CARE (2012)
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
Ivan Chytra et al.
CRITICAL CARE (2012)
Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection
Brett C. McWhinney et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy
A. R. H. van Zanten et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
William K. Lau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
Mohammad Reza Rafati et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
SK Kasiakou et al.
LANCET INFECTIOUS DISEASES (2005)
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis
A Lubasch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Serial evaluation of the SOFA score to predict outcome in critically ill patients
FL Ferreira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
DP Nicolau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
分享论文
